Forbion Growth Sponsor Amends enGene Holdings Stake

TL;DR

Forbion Growth Sponsor updated their enGene Holdings filing on 10/18/24. Watch this space.

AI Summary

Forbion Growth Sponsor FEAC I B.V. filed an amendment (No. 1) to its Schedule 13D on October 18, 2024, regarding enGene Holdings Inc. The filing indicates a change in beneficial ownership of the company's common shares. The specific details of the change in ownership percentage or dollar amounts are not explicitly stated in this excerpt, but the amendment signifies an update to their previous filing.

Why It Matters

This amendment signals a potential shift in control or significant investor interest in enGene Holdings, which could impact its stock price and strategic direction.

Risk Assessment

Risk Level: medium — Amendments to Schedule 13D filings often indicate significant changes in a major shareholder's position, which can lead to increased volatility.

Key Players & Entities

• Forbion Growth Sponsor FEAC I B.V. (company) — Filing party
• enGene Holdings Inc. (company) — Subject company
• FORBION GROWTH MANAGEMENT B.V. (company) — Group member
• FORBION GROWTH OPPORTUNITIES FUND I COOPERATIEF U.A. (company) — Group member

FAQ

Key Financial Figures

• $11.50 — ne Common Share at an exercise price of $11.50 per Common Share, subject to adjustment
• $5.31 — ple transactions at prices ranging from $5.31 to $6.30, inclusive. The Reporting Pers
• $6 — actions at prices ranging from $5.31 to $6.30, inclusive. The Reporting Persons un
• $6.31 — ple transactions at prices ranging from $6.31 to $6.40, inclusive. The Reporting Pers
• $5.97 — ple transactions at prices ranging from $5.97 to $6.60, inclusive. The Reporting Pers
• $6.30 — ple transactions at prices ranging from $6.30 to $6.60, inclusive. The Reporting Pers
• $6.07 — ple transactions at prices ranging from $6.07 to $6.67, inclusive. The Reporting Pers
• $6.435 — ple transactions at prices ranging from $6.435 to $6.585, inclusive. The Reporting Per
• $6.50 — ple transactions at prices ranging from $6.50 to $6.62, inclusive. The Reporting Pers
• $6.42 — ple transactions at prices ranging from $6.42 to $6.60, inclusive. The Reporting Pers
• $6.59 — ple transactions at prices ranging from $6.59 to $6.60, inclusive. The Reporting Pers

Filing Documents

• d889944dsc13da.htm (SC 13D/A) — 98KB
• 0001193125-24-239641.txt ( ) — 99KB

of the Schedule 13D is hereby amended to include the following

Item 3 of the Schedule 13D is hereby amended to include the following: The information set forth in Item 5(c) below is incorporated by reference into this Item 3. The securities were acquired using funds from working capital. ITEM5. INTEREST IN SECURITIES OF THE ISSUER. (a) and (b) 1. Sponsor Securities. As of the date hereof, Forbion Growth Sponsor FEAC I B.V. (the Sponsor ) may be deemed to beneficially own 5,502,338 Common Shares, consisting of (a) 3,765,932 Common Shares and (b) 1,736,406 Warrants, with each Warrant exercisable for one Common Share at an exercise price of $11.50 per Common Share, subject to adjustment (collectively, the Sponsor Securities ). The Sponsor Securities represent 12.0% of the Issuers total Common Shares, calculated based on a total of (i) 44,215,577 Common Shares outstanding as of September 6, 2024, as reported in the Quarterly Report on Form 10-Q filed by the Issuer on September 10, 2024, plus (ii) 1,736,406 Common Shares issuable upon the exercise of the Warrants held by the Sponsor. J.M. Bos, C. Lesser, S. Slootweg and W.S.J. Joustra are directors of the Sponsor and have shared voting and investment discretion with respect to the Sponsor Securities and may be deemed to have indirect shared beneficial ownership of the Sponsor Securities held by the Sponsor. J. M. Bos, C. Lesser, S. Slootweg and W.S.J. Joustra each disclaims beneficial ownership over the Sponsor Securities except to the extent of his proportionate pecuniary interest therein. Forbion Growth Opportunities Fund I Cooperatief U.A. ( Forbion Cooperatief ) wholly owns the Sponsor and therefore the Sponsor shares the voting and investment power over the Sponsor Securities held by it with Forbion Cooperatief and, indirectly, with Forbion Cooperatiefs sole director, Forbion Growth Management B.V. (Forbion Management), which exercises voting and investment power through its investment committee (the Investment Committee ), consisting of S. Slootweg, M. A. van Osch,

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this Statement is true, complete and correct. Dated: October 18, 2024 Forbion Growth Sponsor FEAC I B.V. By: /s/ Sander Slootweg Sander Slootweg, Director By: /s/ Wouter Joustra Wouter Joustra, Director Forbion Growth Opportunities Fund I Cooperatief U.A. By: /s/ Sander Slootweg Sander Slootweg, on behalf of Forbion Growth Management B.V., Director By: /s/ Wouter Joustra Wouter Joustra, on behalf of Forbion Growth Management B.V., Director Forbion Growth Management B.V. By: /s/ Sander Slootweg Sander Slootweg, Director By: /s/ Wouter Joustra Wouter Joustra, Director CUSIP No. 29286M105 Schedule 13D SCHEDULE A CERTAIN INFORMATION CONCERNING DIRECTORS AND EXECUTIVE OFFICERS OF THE REPORTING PERSONS Directors and Executive Officers of the Sponsor. The following table sets forth the name and present principal occupation or employment for each director and each executive officer of the Sponsor. Each of the individuals listed below is employed by the Sponsor, which has a principal business address of 2 Gooimeer 2-35, 1411 DC Naarden, the Netherlands. Each such individual is a citizen of the Netherlands. Name Present Principal Occupation or Employment J.M. Bos Director C. Lesser Director S. Slootweg Director W.S.J. Joustra Director Directors and Executive Officers of Forbion Cooperatief. The following table sets forth the name and present principal occupation or employment for each director and each executive officer of Forbion Cooperatief. The entity listed below is incorporated in the Netherlands and has a principal business address of 2 Gooimeer 2-35, 1411 DC Naarden, the Netherlands. Name Present Principal Occupation or Employment Forbion Growth Management B.V. Director Directors and Executive Officers of Forbion Management. The following table se

View Full Filing

View this SC 13D/A filing on SEC EDGAR